Hummert M, Schoppe L, Bellmann-Strobl J, Siebert N, Paul F, Duchow A
Neurology. 2022; 98(11):e1184-e1196.
PMID: 35082170
PMC: 8935443.
DOI: 10.1212/WNL.0000000000200052.
Erfani P, Phelan J, Orav E, Figueroa J, Jha A, Lam M
Cancer. 2021; 128(5):1093-1100.
PMID: 34767638
PMC: 8837672.
DOI: 10.1002/cncr.34022.
Ocran Mattila P, Babar Z, Suleman F
BMC Health Serv Res. 2021; 21(1):661.
PMID: 34229693
PMC: 8259378.
DOI: 10.1186/s12913-021-06627-6.
Ocran Mattila P, Ahmad R, Hasan S, Babar Z
Front Public Health. 2021; 9:628744.
PMID: 33996712
PMC: 8120029.
DOI: 10.3389/fpubh.2021.628744.
Liu G, Kang S, Wang X, Shang F
Front Oncol. 2021; 11:669195.
PMID: 33987103
PMC: 8111076.
DOI: 10.3389/fonc.2021.669195.
Assessing the financial toxicity in Tunisian cancer patients using the Comprehensive Score for Financial Toxicity (COST).
Mejri N, Berrazega Y, Boujnah R, Rachdi H, El Benna H, Labidi S
Support Care Cancer. 2021; 29(7):4105-4111.
PMID: 33404807
DOI: 10.1007/s00520-020-05944-6.
Use of Multi-Site Radiation Therapy for Systemic Disease Control.
Patel R, Verma V, Barsoumian H, Ning M, Chun S, Tang C
Int J Radiat Oncol Biol Phys. 2020; 109(2):352-364.
PMID: 32798606
PMC: 10644952.
DOI: 10.1016/j.ijrobp.2020.08.025.
Distinct models to assess the cost-effectiveness of EGFR-tyrosine kinase inhibitors for the treatment of metastatic non-small cell lung cancer in the context of the Brazilian Unified Health Care System.
Aguiar Jr P, Roitberg F, Lopes Jr G, Del Giglio A
J Bras Pneumol. 2020; 46(4):e20180255.
PMID: 32490907
PMC: 7567624.
DOI: 10.36416/1806-3756/e20180255.
In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies.
Patel A, Bah M, Weiner D
BioDrugs. 2020; 34(3):273-293.
PMID: 32157600
PMC: 7211204.
DOI: 10.1007/s40259-020-00412-3.
Cost-effectiveness analysis of pembrolizumab plus chemotherapy with PD-L1 test for the first-line treatment of NSCLC.
Wan N, Zhang T, Hua S, Lu Z, Ji B, Li L
Cancer Med. 2020; 9(5):1683-1693.
PMID: 31945265
PMC: 7050096.
DOI: 10.1002/cam4.2793.
Assessing Care Value for Older Patients Receiving Radiotherapy With or Without Cisplatin or Cetuximab for Locoregionally Advanced Head and Neck Cancer.
Saraswathula A, Chen M, Colevas A, Divi V
JAMA Otolaryngol Head Neck Surg. 2019; 145(12):1160-1167.
PMID: 31621810
PMC: 6802372.
DOI: 10.1001/jamaoto.2019.2381.
Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol.
Riva S, Bryce J, De Lorenzo F, Del Campo L, Di Maio M, Efficace F
BMJ Open. 2019; 9(9):e031485.
PMID: 31501130
PMC: 6738930.
DOI: 10.1136/bmjopen-2019-031485.
Early Accountable Care Organization Results in End-of-Life Spending Among Cancer Patients.
Lam M, Zheng J, Orav E, Jha A
J Natl Cancer Inst. 2019; 111(12):1307-1313.
PMID: 30859226
PMC: 6910163.
DOI: 10.1093/jnci/djz033.
Cost-effectiveness of immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer.
Chu J, Choi J, Ostvar S, Torchia J, Reynolds K, Tramontano A
Cancer. 2018; 125(2):278-289.
PMID: 30343509
PMC: 10664966.
DOI: 10.1002/cncr.31795.
A prospective survey of comprehensive score for financial toxicity in Japanese cancer patients: report on a pilot study.
Honda K, Gyawali B, Ando M, Sugiyama K, Mitani S, Masuishi T
Ecancermedicalscience. 2018; 12:847.
PMID: 30079109
PMC: 6057653.
DOI: 10.3332/ecancer.2018.847.
Conflict of interest among Italian medical oncologists: a national survey.
DeCensi A, Numico G, Ballatori E, Artioli F, Clerico M, Fioretto L
BMJ Open. 2018; 8(6):e020912.
PMID: 29961019
PMC: 6042593.
DOI: 10.1136/bmjopen-2017-020912.
Cell death-based treatments of melanoma:conventional treatments and new therapeutic strategies.
Mattia G, Puglisi R, Ascione B, Malorni W, Care A, Matarrese P
Cell Death Dis. 2018; 9(2):112.
PMID: 29371600
PMC: 5833861.
DOI: 10.1038/s41419-017-0059-7.
Cost effectiveness of chemohormonal therapy in patients with metastatic hormone-sensitive and non-metastatic high-risk prostate cancer.
Aguiar Jr P, Barreto C, de Souza Gutierres B, Tadokoro H, de Lima Lopes Jr G
Einstein (Sao Paulo). 2017; 15(3):349-354.
PMID: 29091159
PMC: 5823051.
DOI: 10.1590/S1679-45082017GS4017.
State of play and clinical prospects of antibody gene transfer.
Hollevoet K, Declerck P
J Transl Med. 2017; 15(1):131.
PMID: 28592330
PMC: 5463339.
DOI: 10.1186/s12967-017-1234-4.
The high price of anticancer drugs: origins, implications, barriers, solutions.
Prasad V, De Jesus K, Mailankody S
Nat Rev Clin Oncol. 2017; 14(6):381-390.
PMID: 28290490
DOI: 10.1038/nrclinonc.2017.31.
